Annual CFI
-$214.13 M
+$48.51 M+18.47%
31 December 2023
Summary:
Ionis Pharmaceuticals annual cash flow from investing activities is currently -$214.13 million, with the most recent change of +$48.51 million (+18.47%) on 31 December 2023. During the last 3 years, it has fallen by -$488.60 million (-178.01%). IONS annual CFI is now -178.01% below its all-time high of $274.48 million, reached on 31 December 2020.IONS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$340.80 M
-$403.25 M-645.71%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly cash flow from investing activities is currently -$340.80 million, with the most recent change of -$403.25 million (-645.71%) on 30 September 2024. Over the past year, it has dropped by -$409.51 million (-595.98%). IONS quarterly CFI is now -260.64% below its all-time high of $212.15 million, reached on 31 December 2022.IONS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$228.95 M
-$409.51 M-226.81%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM cash flow from investing activities is currently -$228.95 million, with the most recent change of -$409.51 million (-226.81%) on 30 September 2024. Over the past year, it has dropped by -$253.69 million (-1025.70%). IONS TTM CFI is now -151.07% below its all-time high of $448.34 million, reached on 31 March 2021.IONS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.5% | -596.0% | -1025.7% |
| 3 y3 years | -178.0% | -379.4% | -179.6% |
| 5 y5 years | +77.0% | -10000.0% | +54.7% |
IONS Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -178.0% | +18.5% | -260.6% | at low | -179.6% | +39.7% |
| 5 y | 5 years | -178.0% | +77.0% | -260.6% | at low | -151.1% | +54.7% |
| alltime | all time | -178.0% | +77.0% | -260.6% | +9.2% | -151.1% | +78.8% |
Ionis Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$340.80 M(-645.7%) | -$228.95 M(-226.8%) |
| June 2024 | - | $62.45 M(-17.9%) | $180.55 M(-3.8%) |
| Mar 2024 | - | $76.11 M(-384.9%) | $187.62 M(-187.6%) |
| Dec 2023 | -$214.13 M(-18.5%) | -$26.71 M(-138.9%) | -$214.13 M(-965.8%) |
| Sept 2023 | - | $68.71 M(-1.2%) | $24.73 M(-110.9%) |
| June 2023 | - | $69.52 M(-121.3%) | -$227.91 M(-24.2%) |
| Mar 2023 | - | -$325.64 M(-253.5%) | -$300.73 M(+14.5%) |
| Dec 2022 | -$262.64 M(-234.8%) | $212.15 M(-215.3%) | -$262.64 M(-30.8%) |
| Sept 2022 | - | -$183.93 M(+5466.9%) | -$379.67 M(+414.7%) |
| June 2022 | - | -$3.30 M(-98.9%) | -$73.77 M(-57.0%) |
| Mar 2022 | - | -$287.55 M(-402.3%) | -$171.50 M(-188.0%) |
| Dec 2021 | $194.91 M(-29.0%) | $95.11 M(-22.0%) | $194.91 M(-32.2%) |
| Sept 2021 | - | $121.97 M(-220.7%) | $287.65 M(+7.5%) |
| June 2021 | - | -$101.03 M(-228.1%) | $267.62 M(-40.3%) |
| Mar 2021 | - | $78.86 M(-58.0%) | $448.34 M(+63.3%) |
| Dec 2020 | $274.48 M(-765.0%) | $187.85 M(+84.3%) | $274.48 M(+22.1%) |
| Sept 2020 | - | $101.94 M(+27.9%) | $224.82 M(+80.9%) |
| June 2020 | - | $79.69 M(-183.9%) | $124.28 M(-288.0%) |
| Mar 2020 | - | -$95.01 M(-168.8%) | -$66.11 M(+60.2%) |
| Dec 2019 | -$41.27 M(-95.6%) | $138.19 M(+9799.1%) | -$41.27 M(-91.8%) |
| Sept 2019 | - | $1.40 M(-101.3%) | -$505.67 M(-37.9%) |
| June 2019 | - | -$110.69 M(+57.7%) | -$814.74 M(-24.5%) |
| Mar 2019 | - | -$70.17 M(-78.5%) | -$1.08 B(+16.1%) |
| Dec 2018 | -$929.56 M(+159.4%) | -$326.21 M(+6.0%) | -$929.56 M(+41.4%) |
| Sept 2018 | - | -$307.67 M(-18.0%) | -$657.57 M(+31.5%) |
| June 2018 | - | -$375.17 M(-572.0%) | -$500.00 M(+354.0%) |
| Mar 2018 | - | $79.49 M(-246.6%) | -$110.13 M(-69.3%) |
| Dec 2017 | -$358.29 M(-733.0%) | -$54.21 M(-63.9%) | -$358.29 M(+26.5%) |
| Sept 2017 | - | -$150.10 M(-1121.4%) | -$283.28 M(+48.9%) |
| June 2017 | - | $14.70 M(-108.7%) | -$190.27 M(+25.6%) |
| Mar 2017 | - | -$168.68 M(-910.9%) | -$151.50 M(-367.7%) |
| Dec 2016 | $56.60 M(-194.2%) | $20.80 M(-136.4%) | $56.60 M(-11.2%) |
| Sept 2016 | - | -$57.09 M(-206.8%) | $63.76 M(-30.4%) |
| June 2016 | - | $53.46 M(+35.6%) | $91.57 M(-259.9%) |
| Mar 2016 | - | $39.43 M(+41.0%) | -$57.27 M(-4.6%) |
| Dec 2015 | -$60.05 M(-27.5%) | $27.96 M(-195.5%) | -$60.05 M(-56.7%) |
| Sept 2015 | - | -$29.28 M(-69.3%) | -$138.80 M(+3.6%) |
| June 2015 | - | -$95.39 M(-360.3%) | -$134.01 M(+88.7%) |
| Mar 2015 | - | $36.65 M(-172.2%) | -$71.02 M(-14.3%) |
| Dec 2014 | -$82.85 M(-67.6%) | -$50.79 M(+107.4%) | -$82.85 M(-29.4%) |
| Sept 2014 | - | -$24.49 M(-24.4%) | -$117.33 M(-45.7%) |
| June 2014 | - | -$32.39 M(-230.5%) | -$216.15 M(+0.3%) |
| Mar 2014 | - | $24.82 M(-129.1%) | -$215.60 M(-15.7%) |
| Dec 2013 | -$255.73 M(-1520.8%) | -$85.27 M(-30.8%) | -$255.73 M(+54.6%) |
| Sept 2013 | - | -$123.31 M(+287.2%) | -$165.42 M(+213.8%) |
| June 2013 | - | -$31.84 M(+108.0%) | -$52.72 M(-1739.8%) |
| Mar 2013 | - | -$15.31 M(-404.0%) | $3.21 M(-82.1%) |
| Dec 2012 | $18.00 M(-83.3%) | $5.04 M(-147.5%) | $18.00 M(-60.3%) |
| Sept 2012 | - | -$10.61 M(-144.0%) | $45.33 M(-9.8%) |
| June 2012 | - | $24.09 M(-4715.7%) | $50.24 M(-1.1%) |
| Mar 2012 | - | -$522.00 K(-101.6%) | $50.79 M(-53.0%) |
| Dec 2011 | $108.03 M(+355.9%) | $32.37 M(-667.7%) | $108.03 M(+57.9%) |
| Sept 2011 | - | -$5.70 M(-123.1%) | $68.41 M(-54.4%) |
| June 2011 | - | $24.64 M(-56.6%) | $150.03 M(+129.2%) |
| Mar 2011 | - | $56.72 M(-883.2%) | $65.45 M(+176.2%) |
| Dec 2010 | $23.69 M(-111.2%) | -$7.24 M(-109.5%) | $23.69 M(+50.7%) |
| Sept 2010 | - | $75.91 M(-226.7%) | $15.72 M(-115.8%) |
| June 2010 | - | -$59.94 M(-500.7%) | -$99.62 M(+45.6%) |
| Mar 2010 | - | $14.96 M(-198.3%) | -$68.42 M(-67.8%) |
| Dec 2009 | -$212.29 M(-9.4%) | -$15.21 M(-61.4%) | -$212.29 M(-6.9%) |
| Sept 2009 | - | -$39.43 M(+37.2%) | -$227.91 M(-34.9%) |
| June 2009 | - | -$28.73 M(-77.7%) | -$350.12 M(-0.1%) |
| Mar 2009 | - | -$128.91 M(+318.0%) | -$350.42 M(+49.6%) |
| Dec 2008 | -$234.25 M(+321.0%) | -$30.84 M(-80.9%) | -$234.25 M(+8.5%) |
| Sept 2008 | - | -$161.64 M(+456.9%) | -$215.80 M(+96.3%) |
| June 2008 | - | -$29.02 M(+127.8%) | -$109.93 M(+135.3%) |
| Mar 2008 | - | -$12.74 M(+2.8%) | -$46.73 M(-16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | -$55.64 M(+70.6%) | -$12.39 M(-77.8%) | -$55.64 M(-44.0%) |
| Sept 2007 | - | -$55.77 M(-263.2%) | -$99.40 M(+188.6%) |
| June 2007 | - | $34.18 M(-257.8%) | -$34.45 M(-49.0%) |
| Mar 2007 | - | -$21.66 M(-61.4%) | -$67.61 M(+107.3%) |
| Dec 2006 | -$32.61 M(-169.3%) | -$56.14 M(-711.7%) | -$32.61 M(-187.5%) |
| Sept 2006 | - | $9.18 M(+802.5%) | $37.28 M(-0.7%) |
| June 2006 | - | $1.02 M(-92.4%) | $37.54 M(-33.0%) |
| Mar 2006 | - | $13.34 M(-3.0%) | $56.02 M(+19.0%) |
| Dec 2005 | $47.08 M(-43.8%) | $13.74 M(+45.5%) | $47.08 M(-18.8%) |
| Sept 2005 | - | $9.44 M(-51.6%) | $57.97 M(-2.2%) |
| June 2005 | - | $19.50 M(+343.7%) | $59.27 M(+0.4%) |
| Mar 2005 | - | $4.39 M(-82.2%) | $59.07 M(-29.5%) |
| Dec 2004 | $83.73 M(-653.8%) | $24.64 M(+129.3%) | $83.73 M(+58.6%) |
| Sept 2004 | - | $10.74 M(-44.3%) | $52.80 M(+80.4%) |
| June 2004 | - | $19.29 M(-33.6%) | $29.26 M(-35.0%) |
| Mar 2004 | - | $29.06 M(-561.5%) | $45.01 M(-397.7%) |
| Dec 2003 | -$15.12 M(-75.0%) | -$6.30 M(-50.8%) | -$15.12 M(-18.5%) |
| Sept 2003 | - | -$12.79 M(-136.5%) | -$18.54 M(+197.9%) |
| June 2003 | - | $35.04 M(-212.8%) | -$6.22 M(-90.3%) |
| Mar 2003 | - | -$31.07 M(+219.7%) | -$64.13 M(+6.2%) |
| Dec 2002 | -$60.37 M(-57.9%) | -$9.72 M(+1963.5%) | -$60.37 M(+13.6%) |
| Sept 2002 | - | -$471.00 K(-97.9%) | -$53.14 M(-67.6%) |
| June 2002 | - | -$22.87 M(-16.2%) | -$164.17 M(+5.1%) |
| Mar 2002 | - | -$27.31 M(+995.3%) | -$156.18 M(+8.8%) |
| Dec 2001 | -$143.49 M(+50.4%) | -$2.49 M(-97.8%) | -$143.49 M(-16.7%) |
| Sept 2001 | - | -$111.50 M(+649.2%) | -$172.28 M(+159.2%) |
| June 2001 | - | -$14.88 M(+1.8%) | -$66.46 M(-20.5%) |
| Mar 2001 | - | -$14.61 M(-53.3%) | -$83.55 M(-12.4%) |
| Dec 2000 | -$95.38 M(+1107.3%) | -$31.29 M(+450.4%) | -$95.38 M(+15.1%) |
| Sept 2000 | - | -$5.68 M(-82.2%) | -$82.89 M(+11.1%) |
| June 2000 | - | -$31.97 M(+20.9%) | -$74.61 M(+121.8%) |
| Mar 2000 | - | -$26.44 M(+40.6%) | -$33.64 M(+325.8%) |
| Dec 1999 | -$7.90 M(-186.8%) | -$18.80 M(-823.1%) | -$7.90 M(-176.7%) |
| Sept 1999 | - | $2.60 M(-71.1%) | $10.30 M(-39.1%) |
| June 1999 | - | $9.00 M(-1385.7%) | $16.90 M(+482.8%) |
| Mar 1999 | - | -$700.00 K(+16.7%) | $2.90 M(-68.1%) |
| Dec 1998 | $9.10 M(-159.9%) | -$600.00 K(-106.5%) | $9.10 M(-1616.7%) |
| Sept 1998 | - | $9.20 M(-284.0%) | -$600.00 K(-96.0%) |
| June 1998 | - | -$5.00 M(-190.9%) | -$15.10 M(+619.0%) |
| Mar 1998 | - | $5.50 M(-153.4%) | -$2.10 M(-86.2%) |
| Dec 1997 | -$15.20 M(+34.5%) | -$10.30 M(+94.3%) | -$15.20 M(+53.5%) |
| Sept 1997 | - | -$5.30 M(-166.3%) | -$9.90 M(-595.0%) |
| June 1997 | - | $8.00 M(-205.3%) | $2.00 M(-47.4%) |
| Mar 1997 | - | -$7.60 M(+52.0%) | $3.80 M(-133.6%) |
| Dec 1996 | -$11.30 M(+653.3%) | -$5.00 M(-175.8%) | -$11.30 M(+156.8%) |
| Sept 1996 | - | $6.60 M(-32.7%) | -$4.40 M(-83.7%) |
| June 1996 | - | $9.80 M(-143.2%) | -$27.00 M(-20.1%) |
| Mar 1996 | - | -$22.70 M(-1294.7%) | -$33.80 M(+2153.3%) |
| Dec 1995 | -$1.50 M(-83.7%) | $1.90 M(-111.9%) | -$1.50 M(-54.5%) |
| Sept 1995 | - | -$16.00 M(-633.3%) | -$3.30 M(-126.8%) |
| June 1995 | - | $3.00 M(-68.8%) | $12.30 M(-1330.0%) |
| Mar 1995 | - | $9.60 M(+9500.0%) | -$1.00 M(-89.1%) |
| Dec 1994 | -$9.20 M(+26.0%) | $100.00 K(-125.0%) | -$9.20 M(-30.3%) |
| Sept 1994 | - | -$400.00 K(-96.1%) | -$13.20 M(-14.3%) |
| June 1994 | - | -$10.30 M(-835.7%) | -$15.40 M(+316.2%) |
| Mar 1994 | - | $1.40 M(-135.9%) | -$3.70 M(-49.3%) |
| Dec 1993 | -$7.30 M(-145.1%) | -$3.90 M(+50.0%) | -$7.30 M(-269.8%) |
| Sept 1993 | - | -$2.60 M(-285.7%) | $4.30 M(-65.6%) |
| June 1993 | - | $1.40 M(-163.6%) | $12.50 M(+4.2%) |
| Mar 1993 | - | -$2.20 M(-128.6%) | $12.00 M(-25.9%) |
| Dec 1992 | $16.20 M(-137.1%) | $7.70 M(+37.5%) | $16.20 M(-189.0%) |
| Sept 1992 | - | $5.60 M(+522.2%) | -$18.20 M(-49.4%) |
| June 1992 | - | $900.00 K(-55.0%) | -$36.00 M(-12.8%) |
| Mar 1992 | - | $2.00 M(-107.5%) | -$41.30 M(-5.5%) |
| Dec 1991 | -$43.70 M | -$26.70 M(+118.9%) | -$43.70 M(+157.1%) |
| Sept 1991 | - | -$12.20 M(+177.3%) | -$17.00 M(+254.2%) |
| June 1991 | - | -$4.40 M(+1000.0%) | -$4.80 M(+1100.0%) |
| Mar 1991 | - | -$400.00 K | -$400.00 K |
FAQ
- What is Ionis Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual CFI year-on-year change?
- What is Ionis Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly CFI year-on-year change?
- What is Ionis Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM CFI year-on-year change?
What is Ionis Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of IONS is -$214.13 M
What is the all time high annual CFI for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual cash flow from investing activities is $274.48 M
What is Ionis Pharmaceuticals annual CFI year-on-year change?
Over the past year, IONS annual cash flow from investing activities has changed by +$48.51 M (+18.47%)
What is Ionis Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of IONS is -$340.80 M
What is the all time high quarterly CFI for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly cash flow from investing activities is $212.15 M
What is Ionis Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, IONS quarterly cash flow from investing activities has changed by -$409.51 M (-595.98%)
What is Ionis Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of IONS is -$228.95 M
What is the all time high TTM CFI for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM cash flow from investing activities is $448.34 M
What is Ionis Pharmaceuticals TTM CFI year-on-year change?
Over the past year, IONS TTM cash flow from investing activities has changed by -$253.69 M (-1025.70%)